Schisandrol A protects AGEs-induced neuronal cells death by allosterically targeting ATP6V0d1 subunit of V-ATPase-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Schisandrol A protects AGEs-induced neuronal cells death by allosterically targeting ATP6V0d1 subunit of V-ATPase

Published:2022-10 Issue:10 Volume:12 Page:3843-3860
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Zhou Xiaoqing,Zhao Shaoyang,Liu Tingting,Yao Lu,Zhao Meimei,Ye Xiaoming,Zhang Xiaowen,Guo Qiang,Tu Pengfei,Zeng Kewu

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference52 articles.

1. The risk factors for diabetic peripheral neuropathy: a meta-analysis;Liu;PLoS One,2019

2. Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets;Dewanjee;Eur J Pharmacol,2018

3. Advanced glycation end products role in pathology of diabetic complications;Ahmed;Diabetes Res Clin Pract,2005

4. Cytotoxicity of advanced glycation end products is mediated by oxidative stress;Loske;J Neural Transm,1998

5. The role of lysosome in regulated necrosis;Alu;Acta Pharm Sin B,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scutellarin targets Wnt5a against zearalenone-induced apoptosis in mouse granulosa cells in vitro and in vivo;Journal of Hazardous Materials;2024-02

2. The discovery of a new potent FXR agonist based on natural product screening;Bioorganic Chemistry;2024-02

3. Advances and perspectives in chemical and biological studies of <i>Baphicacanthus cusia</i>: a focus on antitumor constituents;Medicinal Plant Biology;2024

4. Top 10 academic progress on traditional Chinese medicine in 2022;Science of Traditional Chinese Medicine;2023-11-29

5. A comprehensive review on Schisandrin and its pharmacological features;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-09-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3